Hamza, S.A. et al. 2026. The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES. (Feb. 2026), 335–345. DOI:https://doi.org/10.29284/x4mwhb26.